Cargando…
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
Chondrosarcomas are malignant cartilage tumors showing relative resistance to conventional chemo- and radiotherapy. Previous studies showed that chondrosarcoma cells could be sensitized to chemotherapy by inhibiting the Bcl-2 family members Bcl-2, Bcl-xl and Bcl-w using ABT-737. In this study we exp...
Autores principales: | de Jong, Yvonne, Monderer, David, Brandinelli, Emeline, Monchanin, Morgane, van den Akker, Brendy E., van Oosterwijk, Jolieke G., Blay, Jean Yves, Dutour, Aurélie, Bovée, Judith V. M. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155044/ https://www.ncbi.nlm.nih.gov/pubmed/30242253 http://dx.doi.org/10.1038/s41389-018-0084-0 |
Ejemplares similares
-
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015) -
Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy
por: de Graaff, Marieke A, et al.
Publicado: (2016) -
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
por: Yosef, Reut, et al.
Publicado: (2016) -
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2022) -
Bcl-xL in neuroprotection and plasticity
por: Jonas, Elizabeth A., et al.
Publicado: (2014)